Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
THEMIS2-expressie verbetert voorspelling time-to-first-treatment bij CLL
jan 2024 | Leukemie